CoreAge Rx vs Science & Co
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Science & Co head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 75 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Science & Co a bad call — it's best for readers considering a longer compounded treatment plan who will verify the total commitment and cancellation rules before relying on a promotional monthly equivalent. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Science & Co |
|---|---|---|
| Brief Score | 94/100 (A) | 75/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm annual-plan payment schedule Promotional $49/mo equivalent on a 12-month plan; payment and renewal terms unknown. Full price detailsBilling unconfirmed; payment schedule unknown. Promotional $49/month equivalent on a 12-month compounded plan |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm annual-plan payment schedule Promotional $89/mo equivalent on a 12-month plan; payment and renewal terms unknown. Full price detailsBilling unconfirmed; payment schedule unknown. Promotional $89/month equivalent on a 12-month compounded plan |
| Coverage | US only; restrictions by state, confirmed at intake | All 50 states and D.C. advertised; confirm the selected prescription and pharmacy access |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Science & Co: The $49 semaglutide and $89 tirzepatide offers are monthly equivalents on twelve-month promotional plans. Confirm the full payment schedule and renewal price; these are not established month-to-month rates.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.